Sinusoidal obstruction syndrome historical perspective: Difference between revisions
Irfan Dotani (talk | contribs) (Created page with "__NOTOC__ {{Sinusoidal obstruction syndrome}} {{CMG}}; {{AE}} {{PleaseHelp}} ==Overview== ==Historical Perspective== ==References== {{reflist|2}} Category:Hepatology...") |
|||
Line 8: | Line 8: | ||
==Historical Perspective== | ==Historical Perspective== | ||
* This section should include the name of the disease in the first sentence, and give a brief description of the important aspects of the information that is relayed in the rest of the page. | |||
* For an example of the overview section of the historical perspective page, click [[Chronic stable angina historical perspective#overview|here]]. | |||
===Template=== | |||
*'''First Sentence:''' | |||
:[Disease name] was first discovered by [scientist] in [year] during/following [event]. | |||
:OR | |||
:[Disease name] was first described by [scientist] in [year]. | |||
*'''Examples:''' | |||
:Example 1:''Shigella'' was first discovered by Dr. Kiyoshi Shiga following a bacillary dysentery outbreak in Japan in 1896. | |||
:Example 2: Melanoma was first described by Hippocrates in the 5th century BC. | |||
<br> | |||
*'''Additional Sentences:''' | |||
:Additional Sentence 1: In [year], the first [event] occurred/was first reported following/during [event]. | |||
:Additional Sentence 2: In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name]. | |||
:Additional Sentence 3: There have been several outbreaks of [disease] which are summarized below. | |||
:Additional Sentence 4: [Disease name] was first described in [year] by [scientist]. | |||
:Additional Sentence 5: [Risk factor or cause] was first discovered to be associated with [disease] in [year]. | |||
:Additional Sentence 6: In [year], [scientist] was the first to discover the association between [risk factor] and development of [disease]. | |||
:Additional Sentence 7: In [year], [gene] mutations were first identified in the pathogenesis of [disease]. | |||
*'''Examples:''' | |||
:Example 1: In 1918, the first major human influenza pandemic occurred. | |||
:Example 2: In 2003, human-to-human transmission of avian influenza was first reported during the influenza A H5N1 outbreaks in Southeast and Central Asia. | |||
:Example 3: In 1978, the first cell-cytotoxicity assay was developed by Te-Wen Chang to diagnose ''C. difficile'' infection based on fecal toxins A and B. | |||
:Example 4: There have been several outbreaks of avian influenza which are summarized below. | |||
:Example 5: In 1956, Henry Lancaster, an Australian mathematician, was the first to discover the association between UV radiation exposure and development of melanoma. | |||
:Example 6: In 2003, ''BRAF'' mutations were first identified in the pathogenesis of melanoma. | |||
==References== | ==References== |
Revision as of 17:54, 3 January 2018
Sinusoidal obstruction syndrome Microchapters |
Differentiating Sinusoidal obstruction syndrome from Other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Sinusoidal obstruction syndrome historical perspective On the Web |
American Roentgen Ray Society Images of Sinusoidal obstruction syndrome historical perspective |
FDA on Sinusoidal obstruction syndrome historical perspective |
CDC on Sinusoidal obstruction syndrome historical perspective |
Sinusoidal obstruction syndrome historical perspective in the news |
Blogs on Sinusoidal obstruction syndrome historical perspective |
Directions to Hospitals Treating Sinusoidal obstruction syndrome |
Risk calculators and risk factors for Sinusoidal obstruction syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Historical Perspective
- This section should include the name of the disease in the first sentence, and give a brief description of the important aspects of the information that is relayed in the rest of the page.
- For an example of the overview section of the historical perspective page, click here.
Template
- First Sentence:
- [Disease name] was first discovered by [scientist] in [year] during/following [event].
- OR
- [Disease name] was first described by [scientist] in [year].
- Examples:
- Example 1:Shigella was first discovered by Dr. Kiyoshi Shiga following a bacillary dysentery outbreak in Japan in 1896.
- Example 2: Melanoma was first described by Hippocrates in the 5th century BC.
- Additional Sentences:
- Additional Sentence 1: In [year], the first [event] occurred/was first reported following/during [event].
- Additional Sentence 2: In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].
- Additional Sentence 3: There have been several outbreaks of [disease] which are summarized below.
- Additional Sentence 4: [Disease name] was first described in [year] by [scientist].
- Additional Sentence 5: [Risk factor or cause] was first discovered to be associated with [disease] in [year].
- Additional Sentence 6: In [year], [scientist] was the first to discover the association between [risk factor] and development of [disease].
- Additional Sentence 7: In [year], [gene] mutations were first identified in the pathogenesis of [disease].
- Examples:
- Example 1: In 1918, the first major human influenza pandemic occurred.
- Example 2: In 2003, human-to-human transmission of avian influenza was first reported during the influenza A H5N1 outbreaks in Southeast and Central Asia.
- Example 3: In 1978, the first cell-cytotoxicity assay was developed by Te-Wen Chang to diagnose C. difficile infection based on fecal toxins A and B.
- Example 4: There have been several outbreaks of avian influenza which are summarized below.
- Example 5: In 1956, Henry Lancaster, an Australian mathematician, was the first to discover the association between UV radiation exposure and development of melanoma.
- Example 6: In 2003, BRAF mutations were first identified in the pathogenesis of melanoma.